Passive Light-Converting Eyewear for Therapeutic Eye Exposure
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies for treating infectious diseases and health conditions using electromagnetic radiation are limited in effectiveness and safety, particularly for localized infections, and there is a need for non-pharmaceutical solutions that can be integrated into daily life devices.
Innovation Solution
Development of medicinal lighting devices and systems that emit therapeutic wavelengths of light, including UV, visible, and IR radiation, integrated into everyday items such as eyewear, bandages, and electronic displays, to provide anti-infective and photobiomodulation therapy without requiring additional power or user interaction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ionizing radiation is used to treat cancer and tumors, then treatment effectiveness is improved, but safety and harmful side effects worsen
Solution Approach 1:
The patent converts harmful ionizing radiation into beneficial non-ionizing electromagnetic radiation by using light-emitting diodes (LEDs) that emit therapeutic wavelengths. The harmful effect of radiation is transformed into a beneficial photobiomodulation therapy that treats cancer and tumors without the severe side effects of ionizing radiation, thereby resolving the contradiction between treatment effectiveness and safety.
Solution Approach 2:
The patent changes the fundamental parameters of the radiation by transitioning from ionizing to non-ionizing electromagnetic radiation, specifically using visible and infrared light wavelengths. This parameter change maintains the ability to treat tumors while eliminating the harmful effects associated with ionizing radiation, thus resolving the technical contradiction.
2Illumination intensity
If conventional lighting devices are used for illumination, then visibility is improved, but therapeutic effectiveness for infections worsens
Solution Approach 1:
The patent makes lighting devices universal by enabling them to perform both illumination and therapeutic functions simultaneously. The LED-based lighting devices can provide visible light for visibility while also emitting therapeutic wavelengths for anti-infective and photobiomodulation therapy, thus resolving the contradiction between illumination intensity and therapeutic effectiveness.
Solution Approach 2:
The patent merges the functions of illumination and therapy into a single lighting device system. By combining LEDs that emit both visible light and therapeutic wavelengths, the device simultaneously achieves visibility and therapeutic effectiveness, eliminating the need for separate devices and resolving the technical contradiction.
3Reliability
If pharmaceutical treatments are used for infections, then treatment effectiveness is improved, but safety and side effects worsen
Solution Approach 1:
The patent substitutes the chemical-pharmaceutical system with an optical-photophysical system. Instead of using drugs that have chemical side effects, the invention uses photobiomodulation therapy with specific wavelengths of light that trigger biological responses without chemical side effects, thereby resolving the contradiction between treatment effectiveness and safety.
4Reliability
If additional powered therapeutic devices are integrated into daily life items, then therapeutic effectiveness is improved, but device complexity worsens
Solution Approach 1:
The patent enables daily life items to perform therapeutic functions autonomously using their existing power sources and structural components. For example, eyewear uses the device's own power supply and housing to integrate LED therapy lights, eliminating the need for external devices and reducing overall system complexity while maintaining therapeutic effectiveness.
Solution Approach 2:
The patent combines therapeutic LED components with existing daily life item structures, such as integrating light-emitting elements into eyewear frames, bandages, and electronic displays. This merging approach adds therapeutic functionality without requiring separate powered devices, thereby improving therapeutic effectiveness while minimizing increases in device complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These devices effectively kill bacteria, accelerate healing, and improve health outcomes by delivering therapeutic light in new ways, enhancing cellular function and promoting mitochondrial activity, while being safe for continuous use.
Implementation Method 1
Light in the 380-420 nm wavelength is capable of killing or deactivating microorganisms such as but not limited to Gram positive bacteria, Gram negative bacteria, bacterial endospores, and yeast and filamentous fungi
Implementation Method 2
The invention may simultaneously apply and/or project the antimicrobial lighting and the Red and/or IR lighting radiation and/or wavelengths onto and/or near the infections to reduce and/or kill invading and/or unwanted infections and/or microorganisms
Data Source
AI summary
Medicinal eyewear and optical devices are disclosed. A wearable eyewear device includes a lens and a passive light conversion material integrated within at least a portion of the lens. The passive light conversion material is configured to absorb ambient wavelengths of light from at least one of sunlight or artificial light sources and convert at least a portion of the absorbed ambient light into at least one therapeutic wavelength of photobiomodulation (“PBM”) light within a range of 600 nm to 1200 nm. The lens is configured to direct the PBM light toward the user's eye.